Drug Profile
Iso ddA
Alternative Names: RO 245098Latest Information Update: 17 Nov 2006
Price :
$50
*
At a glance
- Originator Roche
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 14 Jun 1995 No-Development-Reported for HIV infections treatment in USA (Unknown route)